Marit Lloyd DVM DABT

Provided oversight and direction of in vivo pre-clinical development and late stage discovery study conduction for the clinical veterinary program. Participated in strategic planning and study design for in house and outsourced preclinical study conduction. • Promoted development of new technologies or processes that improved the quality and efficiency of pre-clinical work with an emphasis on ocular drug and device evaluation. • Designed and initiated a cross training program for veterinary technicians and study technicians to enable greater flexibility and efficiency in daily conduct of studies and animal health maintenance while also increasing career growth opportunities and employee satisfaction.

Organized and led a new department to meet growing demands for high quality pre-clinical studies in support of development candidates. Conducted 100+ pre-clinical GLP and non GLP studies per year. Primary responsibilities included driving customer satisfaction and service for global project development teams, provision of professional expertise in study design and result interpretation, participation in due diligence evaluations for potential in-licensing/ partnership opportunities and the development of technical staff. • Developed and executed a plan for determining optimal placement of studies and forecasting study needs to improve resource planning and management. • Established and maintained a strong partnership with Ocular Services On Demand (OSOD), a globally recognized group of renowned ophthalmology experts with a focus on the development of ophthalmic drugs and devices that led to improved consistency, quality and effectiveness of all ocular development projects. • Established an Ocular Imaging center of excellence for the pre-clinical evaluation of drug and device candidates.

Responsible for creation and oversight of an in house in vivo discovery/development group. Represented the preclinical group on Development Project teams to help to design and oversee the implementation of the preclinical development program for small and large molecule drug candidates. • Co-Authored IND documents for successful submission to the FDA • Initiated and coordinated/monitored preclinical toxicology and PK studies at large and small CROs. • Participated in due diligence review of potential partnership opportunities. • Interfaced with and provided scientific and logistical support for smaller virtual companies funded by Abraxis • Created and managed a highly skilled and effective team to design and carry out in vivo discovery and early development studies in support of the Abraxis pipeline. • Established an in vivo imaging program for oncology drug candidates.

Served a business development role through participation at trade shows and regular interaction with potential clients from a scientific and business standpoint. Served as backup to the laboratory director and was heavily involved in budgeting and contract bidding. Responsible for the overall management and administration of the laboratory animal health and welfare program for a small GLP CRO specializing in medical device, ocular and wound healing preclinical study conduction. Played a major role as study director, staff surgeon, and client relations management. • Active interaction in FDA, USDA and client audits. • Worked closely with clients and consulting experts to develop models for multiple orthopedic, ophthalmic, dermal and interventional drugs and devices.